Search

Astellas Pharma Inc. US
  • Top MenuAbout
    U.S. Corporate Profile
    Learn more about Astellas U.S.
    Read More
    • Company Facts
      • Astellas Fact Sheet
      • Integrated Report
    • Contact Us
    • Ethics & Compliance
    • Governance
    • Group Code of Conduct
    • Locations
    • Philosophy
      • Charter of Corporate Conduct
    • Policies & Position Statements
    • Political Contributions
    • Regulations
      • State Regulations
        • California Declaration of Comprehensive Compliance Program
        • Vermont’s Pharmaceutical Marketer Price Disclosure
        • Wholesale Acquisition Cost Information for Colorado Prescribers
        • Wholesale Acquisition Cost Information for Connecticut Prescribing Practitioners and Pharmacists
      • Consumer Product Safety Commission Regulations
    • U.S. Corporate Profile
      • Locations
    • U.S. Leadership
    • U.S. Products
      • Medical Safety
        • Safety Data Sheets (v 3.0)
    • Vision & Strategy
  • Top MenuInnovation
    Clinical Trials
    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...
    Read More
    • Areas of Interest
    • Partnering
    • R&D
      • Approach
      • Clinical Trials
      • Ethics & Principles
      • Pipeline
  • Top MenuSUSTAINABILITY
    Changing Tomorrow Day
    Read about our annual day of service.
    Read More
    • Changing Tomorrow Day
    • Corporate Grants
    • COVID-19 Community Response
    • Employee Impact
  • Top MenuNews
    Integrated Report
    Read about our latest progress around our Corporate Strategic Plan.
    Read More
    • Articles
    • Integrated Report
    • Media Inquiries
    • News Releases
      • Stories
      • Corporate
      • Corporate Awards
      • Corporate Social Responsibility
      • Our People
      • Therapeutic Area News
    • Statements
    • Video Gallery

Stakeholders menu

  • COVID-19 Response
  • Patient Focus
    • Support for Patients
      • Astellas Pharma Support Solutions
    • Issues that Matter to You
    • Patient Centricity
    • Patient Partnerships
    • U.S. Products
  • Careers
  • Partnering
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • US
  • WORLDWIDE - US
  1. Home
  2. About
  3. U.S. Products
  4. Medical Safety
  5. Safety Data Sheets (v 3.0)

Safety Data Sheets (v 3.0)

Important Notice

This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Close

Please click on the product to view SDS information.

ADENOCARD
AMBISOME
ASTAGRAF XL
CRESEMBA 74.5 mg CAPSULES
CRESEMBA 186.3 mg CAPSULES
CRESEMBA (ISAVUCONAZONIUM SULFATE) FOR INJECTION
IZERVAY
LEXISCAN (REGADENOSON) INJECTION
MYCAMINE (MICAFUNGIN SODIUM) FOR INJECTION
MYRBETRIQ
MYRBETRIQ™ (MIRABEGRON FOR ORAL SUSPENSION) GRANULES
PADCEV™ (enfortumab vedotin-ejfv) for injection
PROGRAF (TACROLIMUS) GRANULES
PROGRAF CAPSULES
PROGRAF INJECTION
PROTOPIC OINTMENT
TARCEVA
VESICARE
VESIcare LS™ (solifenacin succinate) 1 mg/mL Oral Suspension
VEOZAH TABLETS
VYLOY (Zolbetuximab) for Injection
XOSPATA TABLETS
XTANDI (ENZALUTAMIDE) CAPSULES
XTANDI (ENZALUTAMIDE) TABLETS

 

About

  • Company Facts
    • Astellas Fact Sheet
    • Integrated Report
  • Contact Us
  • Ethics & Compliance
  • Governance
  • Group Code of Conduct
  • Locations
  • Philosophy
    • Charter of Corporate Conduct
  • Policies & Position Statements
  • Political Contributions
  • Regulations
    • State Regulations
      • California Declaration of Comprehensive Compliance Program
      • Vermont’s Pharmaceutical Marketer Price Disclosure
      • Wholesale Acquisition Cost Information for Colorado Prescribers
      • Wholesale Acquisition Cost Information for Connecticut Prescribing Practitioners and Pharmacists
    • Consumer Product Safety Commission Regulations
  • U.S. Corporate Profile
    • Locations
  • U.S. Leadership
  • U.S. Products
    • Medical Safety
      • Safety Data Sheets (v 3.0)
  • Vision & Strategy
Astellas LogoAstellas Changing Tomorrow

Follow us on social media

Facebook icon Linkedin icon Twitter icon

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • HEALTH DATA POLICY
  • COOKIES POLICY
  • ACCESSIBILITY
  • LEGAL DISCLAIMER
  • CONTACT US
© 2023 Astellas Pharma US, Inc.

Update Cookies Preferences